Medication info
Lerogen (Levocetirizine Hydrochloride)

Lerogen (Levocetirizine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Levocetirizine Hydrochloride›5mg / 1 tablet
Manufacturer / importer
Nexpharm Korea Co., Ltd.
Appearance
White or pale yellow oval film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202001353 · Notified 2020.02.26 · Insurance code 662504370

Summary

Main use
Relief of allergic rhinitis, urticaria, and itching associated with dermatitis and eczema (in combination with a topical agent)
Who takes it
Adults · Children
Adult dose
Adults: Administer 1 tablet (equivalent to 5mg of levocetirizine hydrochloride) orally once daily, regardless of meals. The dose may be adjusted as appropriate according to age and symptoms. In patients with renal impairment, adjust the dose according to renal function (estimated glomerular filtration rate (eGFR)). Normal renal function (≥ 90 mL/min): 1 tablet per dose, once daily Mild renal impairment (60 -< 90 mL/min): 1 tablet per dose, once daily Moderate renal impairment (30 -< 60 mL/min): 1 tablet per dose, once every 2 days Severe renal impairment (15 -< 30 mL/min, not requiring dialysis): 1 tablet per dose, once every 3 days End-stage renal disease (< 15 mL/min, requiring dialysis treatment): Contraindicated
Child dose
Children aged 6 years and older: Administer 1 tablet (equivalent to 5mg of levocetirizine hydrochloride) orally once daily, regardless of meals. The dose may be adjusted as appropriate according to age and symptoms.

Ingredients

Manufacturer
Nexpharm Korea Co., Ltd.

Efficacy & effects

Relief of allergic rhinitis, urticaria, and itching associated with dermatitis and eczema (in combination with a topical agent)

  • Seasonal allergic rhinitis
  • perennial allergic rhinitis
  • persistent allergic rhinitis
  • chronic idiopathic urticaria
  • dermatitis with itching
  • eczema
View approved original text

This medication alleviates symptoms of seasonal or perennial allergic rhinitis and is effective for chronic idiopathic urticaria. Additionally, it is utilized in conjunction with hydrocortisone topical preparations for the treatment of dermatitis and eczema accompanied by itching. It is used to assist in improving the quality of life for patients through symptom relief.

How to take

Adult dose

Adults: Administer 1 tablet (equivalent to 5mg of levocetirizine hydrochloride) orally once daily, regardless of meals. The dose may be adjusted as appropriate according to age and symptoms. In patients with renal impairment, adjust the dose according to renal function (estimated glomerular filtration rate (eGFR)). Normal renal function (≥ 90 mL/min): 1 tablet per dose, once daily Mild renal impairment (60 -< 90 mL/min): 1 tablet per dose, once daily Moderate renal impairment (30 -< 60 mL/min): 1 tablet per dose, once every 2 days Severe renal impairment (15 -< 30 mL/min, not requiring dialysis): 1 tablet per dose, once every 3 days End-stage renal disease (< 15 mL/min, requiring dialysis treatment): Contraindicated

Child dose

Children aged 6 years and older: Administer 1 tablet (equivalent to 5mg of levocetirizine hydrochloride) orally once daily, regardless of meals. The dose may be adjusted as appropriate according to age and symptoms.

Precautions

This medication should not be used by patients with allergies to specific components or those hypersensitive to hydroxyzine or piperazine derivatives. Patients with end-stage renal disease or those undergoing dialysis should not be administered this medication. It should not be used in infants under 1 year of age, and children under 6 years should be given the liquid form instead of the tablet form. This tablet contains lactose; therefore, patients with lactose intolerance or specific genetic lactose metabolism disorders should avoid taking it. Patients with impaired kidney or liver function, as well as the elderly, should use this medication with caution as blood concentrations may increase. Side effects related to the nervous system such as drowsiness, headache, and dizziness may occur when taking this medication, as well as hypersensitivity reactions like gastrointestinal symptoms or skin rashes. Care is necessary for activities requiring concentration such as driving or operating machinery after taking this medication, and it should be avoided in combination with alcohol or central nervous system depressants. Patients at risk of urinary retention or those with epilepsy need special attention when using this medication. Pregnant or breastfeeding women must consult a doctor before using this medication, as the effects on the fetus or newborn have not been fully elucidated. Dosage adjustments are required for children and the elderly, particularly reducing the dose for the elderly due to decreased kidney function. If undergoing allergy testing, it is advisable to discontinue this medication 3-5 days prior to testing. In cases of overdose, symptoms such as drowsiness or agitation may occur, and there is no specific antidote; treatment should be symptomatic, and blood dialysis is ineffective in eliminating this medication.

Side effects

  • Drowsiness
  • lethargy
  • headache
  • numbness
  • anxiety
  • fatigue
  • tiredness
  • dizziness
  • heaviness in the head
  • excitement
Show 76 more
  • thirst
  • dry lips
  • nausea
  • loss of appetite
  • stomach discomfort
  • dyspepsia
  • abdominal pain
  • stomach pain
  • abdominal discomfort
  • vomiting
  • gastrointestinal disorders
  • diarrhea
  • cheilitis
  • taste disturbances
  • tachycardia
  • arrhythmia
  • increased blood pressure
  • palpitations
  • vasculitis
  • leukopenia
  • neutropenia
  • lymphocytosis
  • eosinophilia
  • monocytosis
  • thrombocytosis
  • thrombocytopenia
  • photosensitivity
  • anaphylactic shock
  • edema
  • rash
  • pruritus
  • angioedema
  • blurred vision
  • conjunctival hyperemia
  • ocular motor seizures
  • elevated AST
  • elevated ALT
  • elevated Al-P
  • elevated total bilirubin
  • elevated BUN
  • diabetes
  • hematuria
  • pharyngitis
  • cough
  • nosebleed
  • bronchospasm
  • hearing abnormalities
  • visual disturbances
  • chest pain
  • irregular menstruation
  • tinnitus
  • fever
  • otitis media
  • aggressiveness
  • hallucinations
  • depression
  • seizures
  • perceptual disturbances
  • dyspnea
  • urticaria
  • fixed drug eruption
  • vision impairment
  • hepatitis
  • myalgia
  • arthralgia
  • weight gain
  • increased appetite
  • insomnia
  • suicidal thoughts
  • dizziness
  • syncope
  • tremors
  • urinary disturbances
  • urinary retention
  • nightmares
  • pruritus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container protected from light. Additionally, it is important to maintain storage at a temperature between 1 to 30 degrees Celsius to preserve the medication's efficacy.

Appearance and packaging

Appearance

White or pale yellow oval film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.